AllPeptides.eu - Advanced Peptide Research
    Research-use-only hub
    2 variants

    Educational protocol hub

    5-Amino-1MQ: protocol variants and reconstitution resources

    Educational hub for 5-Amino-1MQ, grouping 2 available protocol variants with links to the exact dosage and reconstitution pages.

    What this hub covers

    This page groups the available 5-Amino-1MQ protocol variants so readers can choose the exact vial-size guide without mixing formats.

    Reconstitution workflow

    Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.

    Research-only context

    All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.

    Available protocol variants

    Choose the exact guide you want to view.

    5-Amino-1MQ

    10mg

    5-Amino-1MQ dosing protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and increase intracellular NAD+ levels. By inhibiting NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency. This educational protocol outlines a subcutaneous injection approach.

    View protocol

    5-Amino-1MQ

    50mg

    5-Amino-1MQ dosing protocols center on this selective NNMT inhibitor studied for supporting fat metabolism, preserving lean mass, and increasing intracellular NAD+ levels. This protocol outlines a subcutaneous approach using the larger 50 mg vial for extended use.

    View protocol

    Related research resources

    Internal links that help readers and search engines understand this peptide topic cluster.

    References

    1. Kraus D et al. Nature 2014 — Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
      View Source
    2. PMC (2024) — NNMT inhibition mitigates obesity-associated metabolic dysfunctions
      View Source
    3. Frontiers in Pharmacology (2024) — NNMT: a new therapeutic target for metabolic syndrome
      View Source
    4. PubMed (2021) — Pharmacokinetic study of 5-amino-1-methylquinolinium
      View Source
    5. Journal of Medicinal Chemistry (ACS) — NNMT inhibitors with enhanced potency
      View Source

    Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu